Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in ...
If preclinical findings were translated into the clinic, they could shorten the ...
At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide mor...
UK Government drug sale clawbacks must be eased for pharma innovation to meet it...
Atsena Therapeutics has completed an oversubscribed Series C financing round, ra...
Recent innovations include engineering CAR T-cells to overcome the immunosuppres...
According to a factsheet published by the Trump administration, pharmaceuticals ...
Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-dru...
In the intricate realm of medical diagnostics, the nuances of language can signi...
DULUTH, Minn.—The aquaculture industry in the Great Lakes region faces an intric...
Researchers at The University of Texas at Dallas have embarked on a groundbreaki...
Neuroscience Advocate: Dr. Lana Ruvolo Grasser Takes on Early Career Policy Amba...
Researchers at the ValeroLab in the Viterbi School of Engineering have taken gro...
Retirement and Resilience: The Impact of Exercise on Mental Fatigue in Older Adu...
In a significant stride towards improving the health outcomes of newborns with c...
